Memory CD4+ T cells from MS patients have been reported to recognize several neuroantigens, particularly myelin antigens, including myelin oligodendrocyte glycoprotein (MOG) and MBP [170,171], and T cell responses against these autoantigens are pathogenic in its animal model EAE [151]. Here, MBP is linked to myeloid sarcoma.